Delivery Order SPE2DR25D1004-SPE2DR26FSVW1
- Not listed
- The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on October 30, 2025, with completion scheduled for November 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.06 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on October 17, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's existing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 MG tablets (30-count packaging) with a completion date of December 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on September 5, 2025, with a ceiling value of $1,385.52 and completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,920.26 and an ultimate completion date of December 22, 2025. The contract is unclassified as a set-aside award and represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 MG tablets (30-count units) valued at $2,920.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by January 2, 2026, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents one...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,460.13 for ORGOVYX 120 mg tablets (30-count units) with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $26,282.34 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This is a firm fixed-price contract with an ultimate completion date of January 2, 2026, and no set-aside designation was utilized in the award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor fulfilling this order under its broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price contract structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is listed as the vendor's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit of use packaging) with a firm fixed price structure. The contract, awarded on August 27, 2025, carries an ultimate completion date of September 18, 2025 and represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSVW1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract valued at $1,460.13. The award, issued December 2, 2025, is a non-set-aside competitively awarded delivery order with an ultimate completion date of December 23, 2025. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, serving the federal government's pharmaceutical supply requirements through the Defense Logistics Agency's medical supply chain. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other medical commodities. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical pharmaceutical vendor within the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/1/25 |